A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...

Chemotherapy selection traditionally relies on tumor tissue of origin. However, since genetic alterations drive tumor behavior, it remains unclear if mutations can better predict response. We ...

Prognosis and clinical management of patients with acute myeloid leukemia (AML) is determined by the genetic profile of the underlying disease. In addition to classical cytogenetic aberrations, ...